Literature DB >> 25131294

First report of spondylodiscitis due to vancomycin heteroresistant Staphylococcus capitis in immunocompetent host.

Claudia Bianco1, Fabio Arena1, Barbara Rossetti2, Giacinta Tordini1, Lucia Migliorini2, Paolo Galluzzi3, Alfonso Cerase3, Andrea De Luca2, Gian Maria Rossolini4, Francesca Montagnani5.   

Abstract

We report a successfully treated case of spondylodiscitis and bloodstream infection due to vancomycin heteroresistant Staphylococcus capitis, in an adult immunocompetent patient with multiple antibiotics intolerance. S. capitis is rarely involved in osteomyelitis and, to our knowledge, this is the first report of vancomycin heteroresistance phenomenon in an S. capitis strain causing spondylodiscitis.
Copyright © 2014 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Spondylodiscitis; Staphylococcus capitis; Vancomycin heteroresistance

Mesh：

Substances：

Year:  2014        PMID： 25131294     DOI： 10.1016/j.jiac.2014.04.004

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN： 1341-321X            Impact factor:   2.211


  3 in total

1.  Methods to Evaluate Colistin Heteroresistance in Acinetobacter baumannii.

Authors:  Edgar X Sherman; Jessie E Wozniak; David S Weiss
Journal:  Methods Mol Biol       Date:  2019

2.  Presence of the neonatal Staphylococcus capitis outbreak clone (NRCS-A) in prosthetic joint infections.

Authors:  Staffan Tevell; Sharmin Baig; Bengt Hellmark; Patricia Martins Simoes; Thierry Wirth; Marine Butin; Åsa Nilsdotter-Augustinsson; Bo Söderquist; Marc Stegger
Journal:  Sci Rep       Date:  2020-12-28       Impact factor: 4.379

3.  Staphylococcus capitis isolated from prosthetic joint infections.

Authors:  S Tevell; B Hellmark; Å Nilsdotter-Augustinsson; B Söderquist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-29       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.